References
1. American Cancer Society. Cancer Facts & Figures 2019 [Internet].
Atlanta, GA: ACS; 2019. Report No.: 500819. Available from:
https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2019/cancer-facts-and-figures-2019.pdf
2. Marur S, Forastiere AA. Head and Neck Cancer: Changing Epidemiology,
Diagnosis, and Treatment. Mayo Clinic Proceedings. 2008
Apr;83(4):489–501.
3. Marur S, D’Souza G, Westra WH, Forastiere AA. HPV-associated head and
neck cancer: a virus-related cancer epidemic. Lancet Oncol. 2010
Aug;11(8):781–9.
4. Viens LJ, Henley SJ, Watson M, Markowitz LE, Thomas CC, Thompson TD,
et al. Human Papillomavirus-Associated Cancers - United States,
2008-2012. MMWR Morb Mortal Wkly Rep. 2016 Jul 8;65(26):661–6.
5. Liederbach E, Kyrillos A, Wang C-H, Liu JC, Sturgis EM, Bhayani MK.
The national landscape of human papillomavirus-associated oropharynx
squamous cell carcinoma. International Journal of Cancer. 2017;140(3).
6. Peterson CE, Khosla S, Chen LF, Joslin CE, Davis FG, Fitzgibbon ML,
et al. Racial differences in head and neck squamous cell carcinomas
among non-Hispanic black and white males identified through the National
Cancer Database (1998-2012). J Cancer Res Clin Oncol. 2016
Aug;142(8):1715–26.
7. Gourin CG, Podolsky RH. Racial disparities in patients with head and
neck squamous cell carcinoma. Laryngoscope. 2006 Jul;116(7):1093–106.
8. Ragin CC, Langevin SM, Marzouk M, Grandis J, Taioli E. Determinants
of head and neck cancer survival by race. Head Neck. 2011
Aug;33(8):1092–8.
9. Mahal BA, Inverso G, Aizer AA, Bruce Donoff R, Chuang S-K. Impact of
African–American race on presentation, treatment, and survival of head
and neck cancer. Oral Oncology. 2014 Dec;50(12):1177–81.
10. Reitzel LR, Nguyen N, Zafereo ME, Li G, Wei Q, Sturgis EM.
Neighborhood deprivation and clinical outcomes among head and neck
cancer patients. Health Place. 2012 Jul;18(4):861–8.
11. Molina MA, Cheung MC, Perez EA, Byrne MM, Franceschi D, Moffat FL,
et al. African American and poor patients have a dramatically worse
prognosis for head and neck cancer: An examination of 20,915 patients.
Cancer. 2008 Nov 15;113(10):2797–806.
12. Shin JY, Yoon JK, Shin AK, Diaz AZ. The influence of insurance
status on treatment and outcomes in oral cavity cancer: an analysis on
46,373 patients. International Journal of Oral and Maxillofacial
Surgery. 2018 Oct;47(10):1250–7.
13. Lenze NR, Farquhar DR, Mazul AL, Masood MM, Zevallos JP. Racial
disparities and human papillomavirus status in oropharyngeal cancer: A
systematic review and meta-analysis. Head Neck. 2018 Dec 18;
14. Divaris K, Olshan AF, Smith J, Bell ME, Weissler MC, Funkhouser WK,
et al. Oral health and risk for head and neck squamous cell carcinoma:
the Carolina Head and Neck Cancer Study. Cancer Causes Control. 2010
Apr;21(4):567–75.
15. D’Souza G, Anantharaman D, Gheit T, Abedi-Ardekani B, Beachler DC,
Conway DI, et al. Effect of HPV on head and neck cancer patient
survival, by region and tumor site: A comparison of 1362 cases across
three continents. Oral Oncol. 2016;62:20–7.
16. Chu KP, Habbous S, Kuang Q, Boyd K, Mirshams M, Liu F-F, et al.
Socioeconomic status, human papillomavirus, and overall survival in head
and neck squamous cell carcinomas in Toronto, Canada. Cancer
Epidemiology. 2016 Feb;40:102–12.
17. Stein E, Lenze NR, Yarbrough WG, Hayes DN, Mazul A, Sheth S.
Systematic review and meta‐analysis of racial survival disparities among
oropharyngeal cancer cases by HPV status. Head & Neck. 2020
Jul 7;hed.26328.
18. Faraji F, Rettig EM, Tsai H-L, El Asmar M, Fung N, Eisele DW, et al.
The prevalence of human papillomavirus in oropharyngeal cancer is
increasing regardless of sex or race, and the influence of sex and race
on survival is modified by human papillomavirus tumor status. Cancer.
2019 01;125(5):761–9.
19. Pike LRG, Royce TJ, Mahal AR, Kim DW, Hwang WL, Mahal BA, et al.
Outcomes of HPV-Associated Squamous Cell Carcinoma of the Head and Neck:
Impact of Race and Socioeconomic Status. J Natl Compr Canc Netw.
2020;18(2):177–84.
20. Zevallos JP, Sandulache VC, Hamblin J, Skinner HD, Kramer J, Hartman
CM, et al. Impact of race on oropharyngeal squamous cell carcinoma
presentation and outcomes among veterans. Head Neck. 2016
Jan;38(1):44–50.
21. Langevin SM, Michaud DS, Eliot M, Peters ES, McClean MD, Kelsey KT.
Regular dental visits are associated with earlier stage at diagnosis for
oral and pharyngeal cancer. Cancer Causes Control. 2012
Nov;23(11):1821–9.
22. Groome PA, Rohland SL, Hall SF, Irish J, Mackillop WJ, O’Sullivan B.
A population-based study of factors associated with early versus late
stage oral cavity cancer diagnoses. Oral Oncol. 2011 Jul;47(7):642–7.
23. Gupta B, Kumar N, Johnson NW. Evidence of past dental visits and
incidence of head and neck cancers: a systematic review and
meta-analysis. Syst Rev. 2019 Feb 4;8(1):43.
24. American Association of Physical Anthropologists. AAPA Statement on
Race & Racism [Internet]. Cleveland, Ohio; 2019 Mar [cited 2019
Oct 25]. Available from:
https://physanth.org/about/position-statements/aapa-statement-race-and-racism-2019/
25. Wierzbicka M, Szyfter K, Milecki P, Składowski K, Ramlau R. The
rationale for HPV-related oropharyngeal cancer de-escalation treatment
strategies. Contemp Oncol (Pozn). 2015;19(4):313–22.